Skip to main content
Advertisement
Home

Main navigation

  • Digital Issue Archive
  • Service Directory
  • Awards
  • Advertise
  • Subscribe now

Secondary

  • Travel Insurance
  • Policies & Partnerships
  • Travel Risk Management
  • Travel Trends
  • International Medical Care
  • Industry Moves
  • Reviews
International Medical Care

Treating traveller's tummy

International Medical Care
27 Aug 2019 | Anthony Harrington
Share
Cartoon image of antibiotics pouring from bottles
Searching for a cure

Looking into the issue of traveller’s tummy, Anthony Harrington highlights the need to move away from the knee-jerk prescription of antibiotics

Keep on reading

Reducing antibiotic use impeded by fears

Reducing antibiotic use impeded by fears

A new study from the University of Warwick in the UK has found that efforts to reduce the use of antibiotics in low-to-middle-income countries could be impeded by fears around...
12 Feb 2019
|
Editorial Team
Research highlights patterns of antibiotics prescribing

Research highlights patterns of antibiotics prescribing

According to new research by Imperial College London, UK, antibiotics prescribing by doctors is influenced by team dynamics and cultures within hospitals. The researchers involved spent more than 500 hours...
15 Nov 2018
|
Editorial Team
New hope for antibiotic treatment

New hope for antibiotic treatment

In a discovery that renews hope for antibiotic treatment, researchers at the University of Edinburgh in the UK have found that bacteria that were thought to be resistant to a...
6 Sep 2018
|
Editorial Team

So-called ‘traveller’s tummy’, or galloping diarrhoea, afflicts as many as half of those who travel to foreign parts. While this statistic is worrisome enough, it masks an even deeper issue, which is that doctors, in developing countries particularly, are very prone to reaching for antibiotics as their first port of call to treat any foreigner who turns up in their surgery with traveller’s tummy.
The problem with this is that the world is finding that antibiotics have been prescribed so freely to both humans and livestock, for a whole range of conditions, that we are in danger of finding ourselves with none, or very few, effective antibiotics in the very near future. 
A world without antibiotics would also be a world where no one would dare to do bowel surgery, and transplants of all kinds would be impossible. There is also the not-altogether irrelevant fact that antibiotics are not particularly useful if the cause of the diarrhoea is viral or fungal, rather than down to bacteria. Antibiotics have no efficacy in the case of viral infections, unless the virus has weakened the individual’s resistance to the point where a bacterial infection has also developed. 
So, as Professor Colin Garner, Chief Executive of the charity Antibiotic Research UK notes, the fact that antibiotics are routinely prescribed for cases of traveller’s tummy in China, for example, is seriously worrying. Antibiotic Research UK recently teamed up with Dr David Brown, the Co- Inventor of Viagra and a prolific and enthusiastic seeker of new drugs and non-microbial cures, in order to support his latest project, which aims to provide a non-antibiotic cure for traveller’s tummy. 

An age-old problem
The project, which Dr Brown is in the process of seeking to put through a pilot human trial in China, involves an innovative cure based on three cheap and easy-to-obtain ingredients. These three ingredients, says Dr Brown, work together to boost the human immune system in a way that none of the three can singularly achieve. The result, he hopes, will be a very fast acting cure for traveller’s tummy that does not rely on antibiotics. 
But first, it is worth considering the scale of the challenge that diarrhoea poses to the medical profession. As Professor Garner notes, and as we have already highlighted, diarrhoea is multi-factorial as far as its causes are concerned. It can be caused by bacteria, by a reaction to unfamiliar spices and foods, or the cause can be viral or even fungal. What is common to all forms of severe diarrhoea … is the speed with which sufferers can become dehydrated, which poses its own dangers.

What is common to all forms of severe diarrhoea, however, is the speed with which sufferers can become dehydrated, which poses its own dangers

“This is an age-old problem and a lot of work has been done on it over the years, but it still causes illness, and in extreme cases, death,” said Professor Garner. “The treatment for diarrhoea in children is pretty well known, and consists of fluids and salt. That tends to be a very effective treatment and is usually administered intravenously.” 
However, Professor Garner pointed out that diarrhoea continues to cause an unacceptably large number of deaths in children in developing countries. According to the World Health Organization (WHO), in 2015, nearly nine million children under the age of five died in developing countries, with diarrhoea being second only to pneumonia as the major cause of these deaths. 

Tackling the underlying infection
Today, perhaps the most frequently used non-antibiotic drug used to combat diarrhoea is Imodium, which has Loperamide as its active ingredient. It should be stressed that Loperamide does not cure diarrhoea, so much as alleviate the symptoms. What happens with diarrhoea, when the small and/or large intestine becomes irritated by whatever agent caused the diarrhoea, is that its squeezing action, which moves faecal matter and liquid through the gut, speeds up. This leaves little time for fluids and electrolytes to be absorbed by the small and large intestine, leading to runny stools and fluid and salt loss, as well as heightening the potential for abdominal cramps. Loperamide calms the gut and slows down digestion, reducing its activity and giving more time for fluids to be absorbed, resulting in firmer stools. 
This can bring rapid relief to an upset stomach, but it may not cure the underlying infection and if the immune system cannot deal with the underlying infection, the condition can worsen to the point where Loperamide fails to be effective. 
Dr Brown has a different approach. “The first thing to be said is that diarrhoea works on the immune system. We have two immune systems, the innate and the adaptive,” he said. The innate immune system is the body’s first line of defence. It covers all the surface areas, including internal surface areas, which means the skin, the nose, eyes, lungs and intestines – wherever the body first comes into contact with micro-organisms. “The innate immune system is very powerful, but occasionally it goes wrong, and some microorganisms can pull a jujitsu stunt on it and turn its strengths against it,” said Brown. This is what happens in part in diarrhoea. In a normal immune response, the system triggers an inflammatory reaction which acts as a call to battle for the killer cells produced by the immune system, and they clean out the troublesome bacteria. 
However, with severe diarrhoea, the inflammation of the small and large intestines goes beyond what is required to trigger a reaction from the killer cells and becomes a major problem in its own right. The system keeps using more and more of the body’s fluids to try to flush out the problem and the intestines become over-active. The real danger then is that lesions develop somewhere in the gut or colon and bacteria enter the bloodstream, causing septic shock, with potentially fatal consequences. 
Dr Brown’s idea is to find relatively benign ways of boosting the immune system so that it can do its job. What he wants to do, he points out, has a parallel with the latest treatments for cancer. “In cancer treatments, there is a transformation happening today. The focus is on using drugs that boost the immune system, as opposed to the traditional approach where drugs were used that killed everything, but hopefully killed the cancer cells first, since cancer cells are the most active and the fastest growing, hence react quicker to the poison.”

In 2015, nearly nine million children under the age of five died in developing countries, with diarrhoea being second only to pneumonia as the major cause of these deaths

An innovative idea
Dr Brown originally specialised in the cardiovascular field and in drug development. Three of his drug inventions are on the market today. He switched into the bacterial field about a decade ago when doing work with the Gates Foundation. “The Foundation funded a study that aimed to reduce baby and child deaths, and that made me aware of the high infant mortality figures from diarrhoea in developing countries. That inspired me to work in this field and traveller’s tummy is such a perennial and persistent problem for everyone who either has to go, or chooses to go, to foreign parts, that it was clearly the area to focus on,” he said. 
The problem became a personal one for him when he started making annual trips to Tibet. “My wife and I travelled there in 2005 and we visited an orphanage there and fell in love with it. We now go there every year for two or three weeks at a time, to provide medical services to the orphanage and to the local community. The challenge, however, is that the orphanage is situated on a mountainside at 10,000 feet above sea level. It is bitterly cold for 19 hours a day and you catch infections there very easily, usually lung infections or diarrhoea, so the routine response is to prescribe antibiotics,” he recalled. 
Already in South India and Tibet, the over-prescription of antibiotics has led to a very high degree of resistance to most antibiotics. “So many of our antibiotics there have a very poor chance of working, and this also held true for the antibiotics I was taking with me on the trip. I was writing up my thinking on antibiotics at the time and the problem was really scary,” he said. “WHO had produced its report on antibiotic resistance in so many microorganisms and it was clear that over prescription was a real problem.” 
Dr Brown was doing his evening meditation when suddenly the idea of combining three common ingredients as a cure for diarrhoea came to him. “The idea came fully formed and from my scientific knowledge and knowledge of the immune system, I was convinced it could work,” he said. 
In the time old tradition of medicine, Dr Brown’s first human subject was himself. “On my next trip to Tibet, a month later, I again had diarrhoea and painful stomach cramps. I had brought the mixture with me and within twenty minutes of my taking it, I felt fine. The stomach cramps had gone and that was the end of the diarrhoea too.” 

Promoting understanding
Dr Brown was Chair of Antibiotic Research UK’s Science Committee and a trustee when he explained his diarrhoea idea to the charity and Professor Garner as CEO. The two then had a meeting in March 2017 organised by the charity with the UK Chief Medical Officer, Dame Sally Davies, who is well known for her work aimed at preventing the indiscriminate use of antibiotics around the world. Dame Sally Davies put them in touch with Professor Paul Little of Southampton University, who has contacts in Hong Kong who specialise in arranging human clinical trials. 
“We are now in the process of setting up a pilot human trial. I cannot release any information about the ingredients and their combination, since one of the criteria for a blind trial is that neither the prescribing physician nor the patient knows what is being administered,” Brown explained. “This is essential since if the cure was widely covered in the press, the placebo group being used for comparative purposes could go and buy the ingredients themselves and dose themselves, rendering the study invalid.”
Dr Brown is also about to launch a website on sepsis to try to promote understanding of the fact that bacterial infections of all sorts are best treated in a more holistic way. “We need to address both the bacteria and the individual immune system, to help antibiotics be more effective in saving lives, just as we now do in cancer therapy. We are still in the Dark Ages as far as our understanding of septic shock is concerned and it can be a real killer with diarrhoea as well. So it is very much a continuation of my interest in finding a cure for traveller’s tummy,” he concluded.

IHHR November 2018 Cover

November 2018
 Issue

Out with ITIJ this month is our latest International Hospitals & Healthcare Review, which focusses on wellbeing cover for expatriates, tech innovations that are spurring travel for treatment, and the healthcare and medical insurance landscape in the UAE.

Read full issue

Anthony Harrington

A freelance journalist and editor, and Director of Harrington Productions Ltd, Anthony writes business reports for ITIJ and the Glasgow Herald Newspaper. He is also the Editorial Director for BizAv Media Ltd., publishers of the quarterly print and online journal Business Aviation Magazine). Anthony has been writing on insurance, pensions, business and aviation topics for some decades now, and plans to do so for a few decades more.

UK pledges stronger safeguards for disabled air passengers

UK pledges stronger safeguards for disabled air passengers

7 Nov 2026
Editorial Team
China’s $259.5bn healthcare spend puts IPMI costs and access in focus

China’s $259.5bn healthcare spend puts IPMI costs and access in focus

2 Nov 2026
Chloe Fox
New Zealand university

Allianz Partners adds 24/7 student support in New Zealand

1 Nov 2026
Chloe Fox
JCI launches global certification to standardise Centers of Excellence GettyImages-2229538647

JCI launches global certification to standardise Centers of Excellence

1 Jul 2026
Chloe Fox
International Medical Care Headlines
Ebola vaccine

CEPI approves funds for Ebola vaccine development

The organisation has provided funds to three candidate vaccines for Bundibugyo Ebola, to tackle the ongoing outbreak originating in the Democratic Republic of the Congo
3 Jun 2026
APRIL International retains top IPMI service rating for fifth consecutive year

APRIL International retains top IPMI service rating for fifth consecutive year

The insurer has topped a broker-led IPMI survey, driven by strong responsiveness, claims performance, and consistent intermediary support across all service categories
1 Jun 2026
|
Siân Yates
telemedicine laptop

South Korea to expand telemedicine services for foreign patients

The East Asian country is a major hub for medical tourism, welcoming two million patients a year, and the change is expected to improve support for them
1 Jun 2026
orient-insurance-and-allianz-partners-launch-sphera-international-healthcare-plans

Orient Insurance and Allianz Partners launch Sphera international healthcare plans

The plans, launched under the Sphera brand, are the product of Orient Insurance’s local knowledge, combined with Allianz Partners’ global healthcare expertise
29 May 2026
Medanta hospital expansion

Medanta Group outlines hospital network expansion plans

The healthcare provider is planning a major expansion of its facilities in the coming years, with five new hospitals planned in four Indian cities
28 May 2026
Italy investigates two suspected Ebola cases in Milan linked to Uganda aid workers

Two suspected Ebola cases in Italy linked to Uganda aid workers test negative

The suspected Ebola cases in Milan involving aid workers returning from Uganda underscore escalating cross-border transmission risks linked to the ongoing outbreak
26 May 2026
|
Chloe Fox
Anthropic and Gates Foundation launch $200m AI partnership focused on global health and education

Anthropic and Gates Foundation launch $200m AI partnership focused on global health and education

The new four-year partnership aims to expand access to AI tools and infrastructure across healthcare and education systems
26 May 2026
|
Siân Yates
Dubai UAE skyline night

UAE to build universal healthcare system

The system, which will be underpinned by a national health insurance scheme, aims to provide international-standard healthcare provision to all citizens
25 May 2026
Read More International Medical Care News
H&H February 2025

February 2025
 Issue

Offering readers a deep dive into the issues facing providers and payers of healthcare services around the world. Cost containment, international patient department development, the role of AI in healthcare delivery and more.

Read full issue

International Medical Care Long Reads

Suitcase with sandals

Patients without borders

Global travel has rebounded from its pandemic slump – and medical tourism is no exception. IH&H explores the top destinations for cross-border care, and the treatments patients are seeking
1 May 2026
|
Editorial Team
Woman in airport

Canadian patients look abroad for healthcare relief

Milan Korcock shares details about Canadians bypassing domestic waiting lists and heading abroad for care, exploring why the trend is accelerating, which treatments are most affected, and how insurers are...
1 May 2026
|
Milan Korcok
Image of south korea landscape

South Korea’s medical tourism surge

Chloe Fox speaks to industry experts about South Korea’s rise as a medical tourism hub, the global demand for K-beauty and advanced treatments, and the patient-focused services shaping the sector’s...
1 May 2026
|
Chloe Fox
Singapre city skyline

Singapore’s IPMI shift: a blueprint for Southeast Asia’s healthcare future

Singapore’s regulatory adjustments, provider-payer collaboration, and emphasis on transparency offer practical lessons for healthcare systems in Thailand, Malaysia, Indonesia, and Vietnam as they navigate rapid private healthcare growth, medical inflation, and...
1 May 2026
|
Lauren Haigh
Landscape of India

A passage to India

For the citizens of India, and many expats, public healthcare provision can vary wildly depending on where they are. But what does the private healthcare landscape look like – particularly...
1 May 2026
|
Stefan Mohamed
Illustration of doctors

Safe and responsible adoption of AI in healthcare

David Qu explores how AI is transforming global healthcare, from patient care to drug discovery, while addressing data, bias, privacy, and ethical challenges
1 May 2026
|
Editorial Team
Doctors with graphs behind them

From cash pay to covered benefit: the rise of stem cell therapy in insurance

Jonathan Edelheit, CEO of Healthcare Revolution and Co-Founder and CEO of the Medical Tourism Association, shares how regenerative medicine is now sufficiently mainstream that insurers are changing their benefits structure...
1 May 2026
|
Jonathan Edelheit
Graphs and charts

UK wealth moves signal global shift in premium healthcare demand

Karim Idilby, Chief Growth Officer, AXA Global Healthcare, discusses shifting global wealth migration, the policy forces driving talent mobility, and evolving expectations for international healthcare
1 May 2026
|
Karim Idilby
Read More International Medical Care Long Reads

Why subscribe to ITIJ?

In-depth analysis

In-depth analysis

Unique insights and expert opinions on the latest industry developments

A wider perspective

A wider perspective

Get the global view on the topics that are trending in your region

Breaking news

Breaking news

ITIJ.com has all the latest news relevant to travel insurance and IPMI professionals

Subscribe now
ITIJ IH&H

Footer menu

  • About Us
  • Subscribe
  • Advertise
  • Contact
  • Privacy Policy
  • Terms
  • Voyageur
International Travel & Health Insurance Conferences

Social

  • LinkedIn link
  • Twitter link

© Voyageur Publishing & Events 2026

Close